- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07659808
Clinical Evaluation of Visby Medical Men's Sexual Health Test
Clinical Evaluation of Visby Medical Men's STI PCR Test for Detection of Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG) From Urine in an at Home Setting
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Florida
-
Fort Lauderdale, Florida, Forente stater, 33316
- AHF Wellness Center - Broward
-
Miami Lakes, Florida, Forente stater, 33016
- Healthcare Clinical Data Inc.
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30309
- AHF Wellness Center - Peachtree
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70119
- CrescentCare Sexual Health Center
-
-
Washington
-
Seattle, Washington, Forente stater, 98104
- University of Washington, Virology Research Clinic
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
The study population will consist of subjects with a penis ≥14 years of age who are symptomatic or asymptomatic for sexual transmitted infections (STIs). Subjects will be classified as symptomatic if they report unusual urethral discharge, painful urination, testicular or scrotal pain/swelling, increased urinary frequency, pain or bleeding during sex/intercourse within 7 days prior to enrollment.
To better represent the end users of this product, subjects not actively seeking health care will be recruited into the study with the goal that ~30% of subjects would fall in this category.
Beskrivelse
Inclusion Criteria:
- Willing and able to provide written informed consent and/or assent as required by the reviewing IRB or IEC. Experimental Bill of Rights will also be documented for all study subjects enrolled in applicable states.
- ≥14 years of age at the time of enrollment.
- Subject has a penis at the time of enrollment.
- Able to read and understand instructions provided for the study.
- Willing and able to follow all study procedures, including performing self-collection of one urine sample, running the sample on a Visby test, and using the Visby App to interpret the test results.
Exclusion Criteria:
- Have a medical condition, serious illness, or other circumstance that, in the investigator's judgment, could jeopardize the subject's safety, or could interfere with study procedures.
- Have consumed oral or intramuscular or intravenous antibiotics, within 48 hours prior to enrollment.
- The subject has urinated within the last one (1) hour prior to urine sample collection.
- Have an in-dwelling catheter or practices intermittent catheterization for urinary drainage.
- Have been previously enrolled in this study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Primary Objective
Tidsramme: up to 12 months
|
Evaluate the performance of the Visby test when run by male subjects ≥ 14 years of age, on self-collected first catch urine sample using the audio-visual instructions provided by the Visby App and/or written instructions provided by the printed User Instructions.
|
up to 12 months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TP-400347
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .